Chemours (CC)
(Delayed Data from NYSE)
$24.32 USD
+0.43 (1.80%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $24.33 +0.01 (0.04%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth F Momentum D VGM
Income Statements
Fiscal Year end for The Chemours Company falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6,027 | 6,794 | 6,345 | 4,969 | 5,526 |
Cost Of Goods | 4,721 | 5,178 | 4,964 | 3,902 | 4,463 |
Gross Profit | 1,306 | 1,616 | 1,381 | 1,067 | 1,063 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,551 | 844 | 705 | 700 | 715 |
Income After Depreciation & Amortization | -245 | 772 | 676 | 367 | 348 |
Non-Operating Income | 135 | 132 | 185 | 22 | -264 |
Interest Expense | 208 | 163 | 185 | 210 | 208 |
Pretax Income | -318 | 741 | 676 | 179 | -124 |
Income Taxes | -81 | 163 | 68 | -40 | -72 |
Minority Interest | 1 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -237 | 578 | 608 | 219 | -52 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -238 | 578 | 608 | 219 | -52 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 71 | 1,072 | 1,002 | 696 | 668 |
Depreciation & Amortization (Cash Flow) | 316 | 300 | 326 | 329 | 320 |
Income After Depreciation & Amortization | -245 | 772 | 676 | 367 | 348 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 150.50 | 158.30 | 168.70 | 166.35 | 167.25 |
Diluted EPS Before Non-Recurring Items | 2.82 | 4.66 | 4.00 | 1.98 | 2.51 |
Diluted Net EPS (GAAP) | -1.60 | 3.65 | 3.60 | 1.32 | -0.32 |
Fiscal Year end for The Chemours Company falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 1,350.00 | 1,361.00 | 1,487.00 | 1,643.00 |
Cost Of Goods | NA | 1,064.00 | 1,114.00 | 1,206.00 | 1,233.00 |
Gross Profit | NA | 286.00 | 247.00 | 281.00 | 410.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 174.00 | 262.00 | 317.00 | 806.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 112.00 | -15.00 | -36.00 | -396.00 |
Non-Operating Income | NA | 18.00 | -3.00 | 114.00 | 11.00 |
Interest Expense | NA | 63.00 | 63.00 | 55.00 | 48.00 |
Pretax Income | NA | 67.00 | -81.00 | 23.00 | -433.00 |
Income Taxes | NA | 15.00 | -55.00 | 3.00 | -57.00 |
Minority Interest | NA | 0.00 | 1.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 52.00 | -26.00 | 20.00 | -376.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 52.00 | -27.00 | 20.00 | -376.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 150.05 | 149.94 | 150.19 | 150.61 |
Diluted EPS Before Non-Recurring Items | NA | 0.32 | 0.31 | 0.64 | 1.10 |
Diluted Net EPS (GAAP) | NA | 0.34 | -0.17 | 0.13 | -2.52 |